Overview

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
A Phase I, Open-Label Study To Assess The Effect of ZD6474 (ZACTIMA) On Vascular Permeability In Patients with Advanced Colorectal Cancer and Liver Metastases.
Phase:
Phase 1
Details
Lead Sponsor:
Genzyme, a Sanofi Company